ScopusElsevier Scopus
Status
Active
Coverage
2010–present
Source type
Journal
Open access
Yes
CiteScore
5
SJR · SCImago
0.992
Q2 SJR quartile
H-index
51
Best quartile
Q2 · 63rd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 156 / 428 | 63rd | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Breast Cancer: Targets and Therapy
Breast Cancer: Targets and Therapy is Scopus-indexed (Q2, CiteScore 5), WoS SCIE, DOAJ. Published by Dove Medical Press Ltd.
Checked against the index lists dated .
ISSN 1179-1314Verify ISSN ↗
Publisher: Dove Medical Press Ltd
Scopus · Q2WoS · SCIEOpen Access
5
CiteScore 2025
Q2
Best quartile
3
Indexed in
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Breast Cancer: Targets and Therapy indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q2, CiteScore 5.
What quartile is Breast Cancer: Targets and Therapy in Scopus?
Breast Cancer: Targets and Therapy is Q2 in Oncology (rank 156 of 428), by CiteScore 2025.
What is the impact factor of Breast Cancer: Targets and Therapy?
Breast Cancer: Targets and Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5, which places it in quartile Q2 at the 63rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.992, quartile Q2, with an H-index of 51.
How much does it cost to publish in Breast Cancer: Targets and Therapy?
The publisher lists an article processing charge of about US$2,320 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Breast Cancer: Targets and Therapy and what is its ISSN?
Breast Cancer: Targets and Therapy is published by Dove Medical Press Ltd. Its ISSN is 1179-1314.
Is Breast Cancer: Targets and Therapy in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Breast Cancer: Targets and Therapy open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Breast Cancer: Targets and Therapy? — open metrics via OpenAlex
Breast Cancer: Targets and Therapy has an h-index of 54 and a 2-year mean of 1.94 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q2. On 2-year citations it ranks #204 of 424 Scopus journals in Oncology.
54
h-index
1.94
2-yr mean citations
310
i10-index
761
works indexed
12,848
total citations
Publication fee · open access list price, US$
US$2,320
2-yr mean citations, among Scopus journals in the same subject
#204 of 424 Top 49% Oncology
Breast Cancer: Targets and Therapy published 104 papers in 2025. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Breast Cancer: Targets and Therapy? — latest 98 articles, 2026
In its latest 98 research articles (2026), authors are most often from China (55.4%), Türkiye (8.8%) and United States (7.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Breast Cancer: Targets and Therapy? — indicators, not proof of misconduct
Scopus status: Active. 6 retracted papers are recorded (7.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 6 · 7.9 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration55.4% of recent authorship from China
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Cancer Management and Research Scopus Q2 WoS SCIE DOAJ Cell Health and Cytoskeleton Not in these indexes Clinical and Experimental Gastroenterology Scopus Q2 WoS ESCI DOAJ Clinical, Cosmetic and Investigational Dentistry Scopus Q2 WoS ESCI DOAJ Clinical, Cosmetic and Investigational Dermatology Scopus Q2 WoS SCIE DOAJ Clinical Epidemiology Scopus Q1 WoS SCIE DOAJ Clinical Interventions in Aging Scopus Q2 WoS SCIE DOAJ Clinical Ophthalmology Scopus Q2 WoS ESCI DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.